ABSTRACT
Objective To evaluate the feasibility of continuous paO2 prediction in an intraoperative setting among neurosurgical patients with modern machine learning methods.
Materials and Methods Data were extracted from routine clinical care of lung-healthy, neurosurgical patients. We used recursive feature elimination to identify relevant features for the prediction of paO2. Five machine learning algorithms (gradient boosting regressor, k-nearest neighbors regressor, random forest regressor, support vector regression, multi-layer perceptron regressor) and a multivariate linear regression were then tuned and fitted to the selected features. A performance matrix consisting of Spearman’s ρ, mean absolute percentage error (MAPE) and root mean squared error (RMSE) was finally computed based on the test set and used to compare and rank each algorithm.
Results We analyzed 4,180 patients with 12,497 observations. A total of 20 features were selected from analysis of the training dataset comprising 836 patients with 9,992 observations. The best algorithm, random forest, was able to predict paO2 values with ρ=0.90, MAPE=10.4%, and RMSE=30.9mmHg, closely followed by gradient boosting and multi-layer perceptron. Support vector regression, k-nearest neighbors regressor and the linear regression did not achieve the performance metrics.
Discussion We successfully applied and compared several machine learning algorithms to estimate continuous paO2 values in neurosurgical patients. The random forest regressor performed best over all three categories of the performance matrix.
Conclusion PaO2 can be predicted by perioperative routine data in neurosurgical patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was conducted as a single center retrospective cohort study. The University of Munichs institutional review board approved our protocol (submission 19-539) prior to data access. Due to the retrospective design and anonymization, written consent was not necessary.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
- ABBREVIATIONS
- ABG
- Arterial Blood Gas
- CI
- Confidence Interval
- diffMSE
- MSE Difference
- GBR
- Gradient Boosting Regressor
- IQR
- Interquartile Range
- KNN Regressor
- K-nearest Neighbors Regressor
- MLR
- Multivariate Linear Regression
- MAPE
- Mean Absolute Percentage Error
- MLP Regressor
- Multi-layer Perceptron Regressor
- MLR
- Multivariate Linear Regression
- MSE
- Mean Squared Error
- n
- Number of Observations (multiple per surgery)
- N
- Number of Surgeries
- neg.
- Negative
- paO2
- Partial Arterial Pressure of Oxygen
- pAO2
- Alveolar Oxygen Partial Pressure
- Q1/Q3
- First/Third Quartile
- RFR
- Random Forest Regressor
- RMSE
- Root Mean Squared Error
- SVR
- Support Vector Regression
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.